Clinical Trial Update: ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking

View source ↗

Summary

Pfizer-sponsored observational study of varenicline (Champix) for smoking cessation has completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Champix (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Status: COMPLETED | Results posted: 2011-07-28